English

BARR PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2008-11-06

76 filing records in this dataset, filed from 1995-02-13 to 2008-11-06. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

737 million USD

2008-09-30 · USD

Exact inputs and evidence

Revenue: 737000000 USD Source

Operating margin

12.48%

2008-09-30 · %

Exact inputs and evidence

Operating Income: 92000000 USD Source
Revenue: 737000000 USD Source

Operating cash flow

80 million USD

2008-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 249000000 USD Source
Operating Cash Flow: 169000000 USD Source

Free cash flow

54 million USD

2008-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 249000000 USD Source
Operating Cash Flow: 169000000 USD Source
Capital Expenditure: 88000000 USD Source
Capital Expenditure: 62000000 USD Source

Cash and cash equivalents: 587 million USD 2008-09-30 Source
Exact value

587000000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-11-06.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2007-12-31
Operating income: 9 of 11 periods available· newest 2007-12-31
Net income: 9 of 11 periods available· newest 2007-12-31
Operating cash flow: 8 of 11 periods available· newest 2007-12-31
Capital expenditure: 8 of 11 periods available· newest 2007-12-31
Total assets: 9 of 11 periods available· newest 2007-12-31
liabilities: No compatible figures in this window
Current assets: 9 of 11 periods available· newest 2007-12-31
Current liabilities: 9 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+90.2%

Prior period

USD 1.31 billion

2006-01-01 – 2006-12-31
Current period

USD 2.5 billion

2007-01-01 – 2007-12-31

Exact inputs and evidence

2500582000 − 1314465000 = 1186117000 USD

1314465000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
2500582000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BARR PHARMACEUTICALS INC · 2007-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Year-over-year change in Revenue: 1186117000 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2500582000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#17399 Input fundies:Revenue: 1314465000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-07-003022.txt#17435
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 466.51 million

Prior period

−USD 338.16 million

2006-01-01 – 2006-12-31
Current period

USD 128.35 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

128350000 − -338155000 = 466505000 USD

-338155000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
128350000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BARR PHARMACEUTICALS INC · 2007-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Year-over-year change in Net income: 466505000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 128350000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#20490 Input fundies:NetIncome: -338155000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#20490
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+79.6%

Prior period

USD 213.35 million

2006-01-01 – 2006-12-31
Current period

USD 383.19 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

383187000 − 213346000 = 169841000 USD

213346000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
383187000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BARR PHARMACEUTICALS INC · 2007-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Year-over-year change in Operating cash flow: 169841000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 383187000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21060 Input fundies:OperatingCashFlow: 213346000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21060
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+266.4%

Prior period

USD 33.67 million

2006-01-01 – 2006-12-31
Current period

USD 123.36 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

123358000 − 33667000 = 89691000 USD

33667000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
123358000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BARR PHARMACEUTICALS INC · 2007-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Year-over-year change in Capital expenditure: 89691000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 123358000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21129 Input fundies:CapitalExpenditure: 33667000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21129
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 2.5 billion 100% of revenue
Cost of revenue USD 1.17 billion 47% of revenue
Operating expenses USD 1.01 billion 40% of revenue
Operating income USD 312.65 million 13% of revenue
Tax, interest and other Derived USD 184.3 million 7.4% of revenue
Net income USD 128.35 million 5.1% of revenue

Cash

Operating cash flow USD 383.19 million 15% of revenue
Capital expenditure USD 123.36 million 4.9% of revenue
Free cash flow Derived USD 259.83 million 10% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 18%75%
2003 19%75%
2004 9.4%85%
2004 9.4%85%
2005 21%9.7%70%
2005 17%13%70%
2006 26%11%63%
2006 Net loss: net income was −26% of revenue.
2007 87%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2001-07-01 – 2002-06-30	1188984000	895355000 Derived	293629000	81410000 Derived	212219000	Unavailable	Source 2001-07-01 – 2002-06-30: 1188984000 USD Inspect Revenue Open source 2001-07-01 – 2002-06-30: 293629000 USD Inspect Operating Income Open source 2001-07-01 – 2002-06-30: 212219000 USD Inspect Net Income Open source
2003 2002-07-01 – 2003-06-30	902864000	676284000 Derived	226580000	59014000 Derived	167566000	79711000 Derived	Source 2002-07-01 – 2003-06-30: 902864000 USD Inspect Revenue Open source 2002-07-01 – 2003-06-30: 226580000 USD Inspect Operating Income Open source 2002-07-01 – 2003-06-30: 167566000 USD Inspect Net Income Open source 2002-07-01 – 2003-06-30: 160328000 USD Inspect Operating Cash Flow Open source 2002-07-01 – 2003-06-30: 80617000 USD Inspect Capital Expenditure Open source
2004 2003-07-01 – 2004-06-30	1309088000	1116240000 Derived	192848000	69745000 Derived	123103000	211192000 Derived	Source 2003-07-01 – 2004-06-30: 1309088000 USD Inspect Revenue Open source 2003-07-01 – 2004-06-30: 192848000 USD Inspect Operating Income Open source 2003-07-01 – 2004-06-30: 123103000 USD Inspect Net Income Open source 2003-07-01 – 2004-06-30: 258099000 USD Inspect Operating Cash Flow Open source 2003-07-01 – 2004-06-30: 46907000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	1309088000	1116240000 Derived	192848000	69745000 Derived	123103000	211192000 Derived	Source 2004-01-01 – 2004-12-31: 1309088000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: 192848000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: 123103000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 258099000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 46907000 USD Inspect Capital Expenditure Open source
2005 2004-07-01 – 2005-06-30	1047399000	731062000 Derived	316337000	101349000 Derived	214988000	307878000 Derived	Source 2004-07-01 – 2005-06-30: 1047399000 USD Inspect Revenue Open source 2004-07-01 – 2005-06-30: 316337000 USD Inspect Operating Income Open source 2004-07-01 – 2005-06-30: 214988000 USD Inspect Net Income Open source 2004-07-01 – 2005-06-30: 363035000 USD Inspect Operating Cash Flow Open source 2004-07-01 – 2005-06-30: 55157000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	1047399000	731372000 Derived	316027000	137900000 Derived	178127000	68711000 Derived	Source 2005-01-01 – 2005-12-31: 1047399000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: 316027000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 178127000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 104756000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 36045000 USD Inspect Capital Expenditure Open source
2006 2005-07-01 – 2006-06-30	1314465000	826825000 Derived	487640000	151163000 Derived	336477000	266339000 Derived	Source 2005-07-01 – 2006-06-30: 1314465000 USD Inspect Revenue Open source 2005-07-01 – 2006-06-30: 487640000 USD Inspect Operating Income Open source 2005-07-01 – 2006-06-30: 336477000 USD Inspect Net Income Open source 2005-07-01 – 2006-06-30: 327339000 USD Inspect Operating Cash Flow Open source 2005-07-01 – 2006-06-30: 61000000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	1314465000	827047000 Derived	487418000	825573000 Derived	-338155000	179679000 Derived	Source 2006-01-01 – 2006-12-31: 1314465000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 487418000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -338155000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 213346000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 33667000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	2500582000	2187937000 Derived	312645000	184295000 Derived	128350000	259829000 Derived	Source 2007-01-01 – 2007-12-31: 2500582000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 312645000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 128350000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 383187000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 123358000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.5B 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-06-30	Revenue	1188984000	Revenue: 1188984000 Open source
20032003-06-30	Revenue	902864000	Revenue: 902864000 Open source
20042004-06-30	Revenue	1309088000	Revenue: 1309088000 Open source
20042004-12-31	Revenue	1309088000	Revenue: 1309088000 Open source
20052005-06-30	Revenue	1047399000	Revenue: 1047399000 Open source
20052005-12-31	Revenue	1047399000	Revenue: 1047399000 Open source
20062006-06-30	Revenue	1314465000	Revenue: 1314465000 Open source
20062006-12-31	Revenue	1314465000	Revenue: 1314465000 Open source
20072007-12-31	Revenue	2500582000	Revenue: 2500582000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

90.2% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20022002-06-30	Year over year	No prior comparable period	Revenue: 1188984000 Open source
20032003-06-30	Year over year	-24.1%	Revenue: 902864000 Open source Revenue: 1188984000 Open source
20042004-06-30	Year over year	45%	Revenue: 1309088000 Open source Revenue: 902864000 Open source
20042004-12-31	Year over year	No prior comparable period	Revenue: 1309088000 Open source
20052005-06-30	Year over year	-20%	Revenue: 1047399000 Open source Revenue: 1309088000 Open source
20052005-12-31	Year over year	-20%	Revenue: 1047399000 Open source Revenue: 1309088000 Open source
20062006-06-30	Year over year	25.5%	Revenue: 1314465000 Open source Revenue: 1047399000 Open source
20062006-12-31	Year over year	25.5%	Revenue: 1314465000 Open source Revenue: 1047399000 Open source
20072007-12-31	Year over year	90.2%	Revenue: 2500582000 Open source Revenue: 1314465000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 12.5% 2007

Net margin 5.1% 2007

Free cash flow margin 10.4% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20022002-06-30	Operating margin	24.7%	Operating Income: 293629000 Open source Revenue: 1188984000 Open source
20032003-06-30	Operating margin	25.1%	Operating Income: 226580000 Open source Revenue: 902864000 Open source
20042004-06-30	Operating margin	14.7%	Operating Income: 192848000 Open source Revenue: 1309088000 Open source
20042004-12-31	Operating margin	14.7%	Operating Income: 192848000 Open source Revenue: 1309088000 Open source
20052005-06-30	Operating margin	30.2%	Operating Income: 316337000 Open source Revenue: 1047399000 Open source
20052005-12-31	Operating margin	30.2%	Operating Income: 316027000 Open source Revenue: 1047399000 Open source
20062006-06-30	Operating margin	37.1%	Operating Income: 487640000 Open source Revenue: 1314465000 Open source
20062006-12-31	Operating margin	37.1%	Operating Income: 487418000 Open source Revenue: 1314465000 Open source
20072007-12-31	Operating margin	12.5%	Operating Income: 312645000 Open source Revenue: 2500582000 Open source
20022002-06-30	Net margin	17.8%	Net Income: 212219000 Open source Revenue: 1188984000 Open source
20032003-06-30	Net margin	18.6%	Net Income: 167566000 Open source Revenue: 902864000 Open source
20042004-06-30	Net margin	9.4%	Net Income: 123103000 Open source Revenue: 1309088000 Open source
20042004-12-31	Net margin	9.4%	Net Income: 123103000 Open source Revenue: 1309088000 Open source
20052005-06-30	Net margin	20.5%	Net Income: 214988000 Open source Revenue: 1047399000 Open source
20052005-12-31	Net margin	17%	Net Income: 178127000 Open source Revenue: 1047399000 Open source
20062006-06-30	Net margin	25.6%	Net Income: 336477000 Open source Revenue: 1314465000 Open source
20062006-12-31	Net margin	-25.7%	Net Income: -338155000 Open source Revenue: 1314465000 Open source
20072007-12-31	Net margin	5.1%	Net Income: 128350000 Open source Revenue: 2500582000 Open source
20022002-06-30	Free cash flow margin	Not reported	Revenue: 1188984000 Open source
20032003-06-30	Free cash flow margin	8.8%	Revenue: 902864000 Open source Operating Cash Flow: 160328000 Open source Capital Expenditure: 80617000 Open source
20042004-06-30	Free cash flow margin	16.1%	Revenue: 1309088000 Open source Operating Cash Flow: 258099000 Open source Capital Expenditure: 46907000 Open source
20042004-12-31	Free cash flow margin	16.1%	Revenue: 1309088000 Open source Operating Cash Flow: 258099000 Open source Capital Expenditure: 46907000 Open source
20052005-06-30	Free cash flow margin	29.4%	Revenue: 1047399000 Open source Operating Cash Flow: 363035000 Open source Capital Expenditure: 55157000 Open source
20052005-12-31	Free cash flow margin	6.6%	Revenue: 1047399000 Open source Operating Cash Flow: 104756000 Open source Capital Expenditure: 36045000 Open source
20062006-06-30	Free cash flow margin	20.3%	Revenue: 1314465000 Open source Operating Cash Flow: 327339000 Open source Capital Expenditure: 61000000 Open source
20062006-12-31	Free cash flow margin	13.7%	Revenue: 1314465000 Open source Operating Cash Flow: 213346000 Open source Capital Expenditure: 33667000 Open source
20072007-12-31	Free cash flow margin	10.4%	Revenue: 2500582000 Open source Operating Cash Flow: 383187000 Open source Capital Expenditure: 123358000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 383.2M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-06-30	Operating cash flow	Not reported	No source recorded
20032003-06-30	Operating cash flow	160328000	Operating Cash Flow: 160328000 Open source
20042004-06-30	Operating cash flow	258099000	Operating Cash Flow: 258099000 Open source
20042004-12-31	Operating cash flow	258099000	Operating Cash Flow: 258099000 Open source
20052005-06-30	Operating cash flow	363035000	Operating Cash Flow: 363035000 Open source
20052005-12-31	Operating cash flow	104756000	Operating Cash Flow: 104756000 Open source
20062006-06-30	Operating cash flow	327339000	Operating Cash Flow: 327339000 Open source
20062006-12-31	Operating cash flow	213346000	Operating Cash Flow: 213346000 Open source
20072007-12-31	Operating cash flow	383187000	Operating Cash Flow: 383187000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 259.8M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-06-30	Free cash flow	Unavailable	No source recorded
20032003-06-30	Free cash flow	79711000	Operating Cash Flow: 160328000 Open source Capital Expenditure: 80617000 Open source
20042004-06-30	Free cash flow	211192000	Operating Cash Flow: 258099000 Open source Capital Expenditure: 46907000 Open source
20042004-12-31	Free cash flow	211192000	Operating Cash Flow: 258099000 Open source Capital Expenditure: 46907000 Open source
20052005-06-30	Free cash flow	307878000	Operating Cash Flow: 363035000 Open source Capital Expenditure: 55157000 Open source
20052005-12-31	Free cash flow	68711000	Operating Cash Flow: 104756000 Open source Capital Expenditure: 36045000 Open source
20062006-06-30	Free cash flow	266339000	Operating Cash Flow: 327339000 Open source Capital Expenditure: 61000000 Open source
20062006-12-31	Free cash flow	179679000	Operating Cash Flow: 213346000 Open source Capital Expenditure: 33667000 Open source
20072007-12-31	Free cash flow	259829000	Operating Cash Flow: 383187000 Open source Capital Expenditure: 123358000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2002-06-30	Liabilities / assets	Not reported	Total Assets: 888554000 Open source
2003-06-30	Liabilities / assets	Not reported	Total Assets: 1180937000 Open source
2004-06-30	Liabilities / assets	Not reported	Total Assets: 1333269000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 1352378000 Open source
2005-06-30	Liabilities / assets	Not reported	Total Assets: 1490306000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 1686597000 Open source
2006-06-30	Liabilities / assets	Not reported	Total Assets: 1921419000 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 4961862000 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 4762000000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.18× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20022002-06-30	Current assets / current liabilities	3.58×	Current Assets: 634848000 Open source Current Liabilities: 177455000 Open source
20032003-06-30	Current assets / current liabilities	3.18×	Current Assets: 849786000 Open source Current Liabilities: 267603000 Open source
20042004-06-30	Current assets / current liabilities	4.23×	Current Assets: 878246000 Open source Current Liabilities: 207645000 Open source
20042004-12-31	Current assets / current liabilities	3.91×	Current Assets: 835906000 Open source Current Liabilities: 213836000 Open source
20052005-06-30	Current assets / current liabilities	4.54×	Current Assets: 1000816000 Open source Current Liabilities: 220430000 Open source
20052005-12-31	Current assets / current liabilities	5.83×	Current Assets: 859289000 Open source Current Liabilities: 147492000 Open source
20062006-06-30	Current assets / current liabilities	5.92×	Current Assets: 1108982000 Open source Current Liabilities: 187319000 Open source
20062006-12-31	Current assets / current liabilities	1.72×	Current Assets: 2087999000 Open source Current Liabilities: 1211893000 Open source
20072007-12-31	Current assets / current liabilities	2.18×	Current Assets: 1703000000 Open source Current Liabilities: 780000000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2001-07-01 – 2002-06-30	USD 212.22 million Exact value Exact value: 212219000 USD 2001-07-01 – 2002-06-30: 212219000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BARR PHARMACEUTICALS INC · 2002-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Net Income: 212219000 USD Concept: fundies:NetIncome Period: 2001-07-01 to 2002-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ANetIncome&period=2002-06-30&surface=latest&period_type=duration&start=2001-07-01&unit=USD&dimensions= Input fundies:NetIncome: 212219000 USD (2001-07-01 to 2002-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-04-010080.txt#13112 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2003 2002-07-01 – 2003-06-30	USD 167.57 million Exact value Exact value: 167566000 USD 2002-07-01 – 2003-06-30: 167566000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BARR PHARMACEUTICALS INC · 2003-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Net Income: 167566000 USD Concept: fundies:NetIncome Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ANetIncome&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:NetIncome: 167566000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-05-011030.txt#14601 The citation records this snapshot. The page link may show a newer release later.	USD 160.33 million Exact value Exact value: 160328000 USD 2002-07-01 – 2003-06-30: 160328000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BARR PHARMACEUTICALS INC · 2003-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Operating Cash Flow: 160328000 USD Concept: fundies:OperatingCashFlow Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3AOperatingCashFlow&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 160328000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-05-011030.txt#14885 The citation records this snapshot. The page link may show a newer release later.	USD 80.62 million Exact value Exact value: 80617000 USD 2002-07-01 – 2003-06-30: 80617000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BARR PHARMACEUTICALS INC · 2003-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Capital Expenditure: 80617000 USD Concept: fundies:CapitalExpenditure Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ACapitalExpenditure&period=2003-06-30&surface=latest&period_type=duration&start=2002-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 80617000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-05-011030.txt#14930 The citation records this snapshot. The page link may show a newer release later.	USD 79.71 million Calculation and evidence 160328000 − 80617000 USD Exact free cash flow: 79711000 USD 2002-07-01 – 2003-06-30: 160328000 USD · Inspect Operating Cash Flow · Source 2002-07-01 – 2003-06-30: 80617000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BARR PHARMACEUTICALS INC · 2003-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Free cash flow: 79711000 USD Concept: free-cash-flow Period: 2002-07-01 to 2003-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 160328000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-05-011030.txt#14885 Input fundies:CapitalExpenditure: 80617000 USD (2002-07-01 to 2003-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-05-011030.txt#14930 The citation records this snapshot. The page link may show a newer release later.
2004 2003-07-01 – 2004-06-30	USD 123.1 million Exact value Exact value: 123103000 USD 2003-07-01 – 2004-06-30: 123103000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BARR PHARMACEUTICALS INC · 2004-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Net Income: 123103000 USD Concept: fundies:NetIncome Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ANetIncome&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:NetIncome: 123103000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-06-011017.txt#16549 The citation records this snapshot. The page link may show a newer release later.	USD 258.1 million Exact value Exact value: 258099000 USD 2003-07-01 – 2004-06-30: 258099000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BARR PHARMACEUTICALS INC · 2004-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Operating Cash Flow: 258099000 USD Concept: fundies:OperatingCashFlow Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3AOperatingCashFlow&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 258099000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-06-011017.txt#16861 The citation records this snapshot. The page link may show a newer release later.	USD 46.91 million Exact value Exact value: 46907000 USD 2003-07-01 – 2004-06-30: 46907000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BARR PHARMACEUTICALS INC · 2004-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Capital Expenditure: 46907000 USD Concept: fundies:CapitalExpenditure Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ACapitalExpenditure&period=2004-06-30&surface=latest&period_type=duration&start=2003-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 46907000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-06-011017.txt#16906 The citation records this snapshot. The page link may show a newer release later.	USD 211.19 million Calculation and evidence 258099000 − 46907000 USD Exact free cash flow: 211192000 USD 2003-07-01 – 2004-06-30: 258099000 USD · Inspect Operating Cash Flow · Source 2003-07-01 – 2004-06-30: 46907000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BARR PHARMACEUTICALS INC · 2004-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Free cash flow: 211192000 USD Concept: free-cash-flow Period: 2003-07-01 to 2004-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 258099000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-06-011017.txt#16861 Input fundies:CapitalExpenditure: 46907000 USD (2003-07-01 to 2004-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-06-011017.txt#16906 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	USD 123.1 million Exact value Exact value: 123103000 USD 2004-01-01 – 2004-12-31: 123103000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BARR PHARMACEUTICALS INC · 2004-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Net Income: 123103000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: 123103000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-07-003022.txt#20304 The citation records this snapshot. The page link may show a newer release later.	USD 258.1 million Exact value Exact value: 258099000 USD 2004-01-01 – 2004-12-31: 258099000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BARR PHARMACEUTICALS INC · 2004-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Operating Cash Flow: 258099000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 258099000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-07-003022.txt#20828 The citation records this snapshot. The page link may show a newer release later.	USD 46.91 million Exact value Exact value: 46907000 USD 2004-01-01 – 2004-12-31: 46907000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BARR PHARMACEUTICALS INC · 2004-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Capital Expenditure: 46907000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 46907000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-07-003022.txt#20874 The citation records this snapshot. The page link may show a newer release later.	USD 211.19 million Calculation and evidence 258099000 − 46907000 USD Exact free cash flow: 211192000 USD 2004-01-01 – 2004-12-31: 258099000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 46907000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BARR PHARMACEUTICALS INC · 2004-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Free cash flow: 211192000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 258099000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-07-003022.txt#20828 Input fundies:CapitalExpenditure: 46907000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-07-003022.txt#20874 The citation records this snapshot. The page link may show a newer release later.
2005 2004-07-01 – 2005-06-30	USD 214.99 million Exact value Exact value: 214988000 USD 2004-07-01 – 2005-06-30: 214988000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BARR PHARMACEUTICALS INC · 2005-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Net Income: 214988000 USD Concept: fundies:NetIncome Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ANetIncome&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:NetIncome: 214988000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#18045 The citation records this snapshot. The page link may show a newer release later.	USD 363.04 million Exact value Exact value: 363035000 USD 2004-07-01 – 2005-06-30: 363035000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BARR PHARMACEUTICALS INC · 2005-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Operating Cash Flow: 363035000 USD Concept: fundies:OperatingCashFlow Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3AOperatingCashFlow&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 363035000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-06-011017.txt#16861 The citation records this snapshot. The page link may show a newer release later.	USD 55.16 million Exact value Exact value: 55157000 USD 2004-07-01 – 2005-06-30: 55157000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BARR PHARMACEUTICALS INC · 2005-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Capital Expenditure: 55157000 USD Concept: fundies:CapitalExpenditure Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ACapitalExpenditure&period=2005-06-30&surface=latest&period_type=duration&start=2004-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 55157000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-06-011017.txt#16906 The citation records this snapshot. The page link may show a newer release later.	USD 307.88 million Calculation and evidence 363035000 − 55157000 USD Exact free cash flow: 307878000 USD 2004-07-01 – 2005-06-30: 363035000 USD · Inspect Operating Cash Flow · Source 2004-07-01 – 2005-06-30: 55157000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BARR PHARMACEUTICALS INC · 2005-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Free cash flow: 307878000 USD Concept: free-cash-flow Period: 2004-07-01 to 2005-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 363035000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-06-011017.txt#16861 Input fundies:CapitalExpenditure: 55157000 USD (2004-07-01 to 2005-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-06-011017.txt#16906 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	USD 178.13 million Exact value Exact value: 178127000 USD 2005-01-01 – 2005-12-31: 178127000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BARR PHARMACEUTICALS INC · 2005-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Net Income: 178127000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 178127000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#20490 The citation records this snapshot. The page link may show a newer release later.	USD 104.76 million Exact value Exact value: 104756000 USD 2005-01-01 – 2005-12-31: 104756000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BARR PHARMACEUTICALS INC · 2005-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Operating Cash Flow: 104756000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 104756000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21060 The citation records this snapshot. The page link may show a newer release later.	USD 36.05 million Exact value Exact value: 36045000 USD 2005-01-01 – 2005-12-31: 36045000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BARR PHARMACEUTICALS INC · 2005-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Capital Expenditure: 36045000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 36045000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21129 The citation records this snapshot. The page link may show a newer release later.	USD 68.71 million Calculation and evidence 104756000 − 36045000 USD Exact free cash flow: 68711000 USD 2005-01-01 – 2005-12-31: 104756000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 36045000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BARR PHARMACEUTICALS INC · 2005-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Free cash flow: 68711000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 104756000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21060 Input fundies:CapitalExpenditure: 36045000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21129 The citation records this snapshot. The page link may show a newer release later.
2006 2005-07-01 – 2006-06-30	USD 336.48 million Exact value Exact value: 336477000 USD 2005-07-01 – 2006-06-30: 336477000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BARR PHARMACEUTICALS INC · 2006-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Net Income: 336477000 USD Concept: fundies:NetIncome Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ANetIncome&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:NetIncome: 336477000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#18045 The citation records this snapshot. The page link may show a newer release later.	USD 327.34 million Exact value Exact value: 327339000 USD 2005-07-01 – 2006-06-30: 327339000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BARR PHARMACEUTICALS INC · 2006-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Operating Cash Flow: 327339000 USD Concept: fundies:OperatingCashFlow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3AOperatingCashFlow&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 327339000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-06-011017.txt#16861 The citation records this snapshot. The page link may show a newer release later.	USD 61 million Exact value Exact value: 61000000 USD 2005-07-01 – 2006-06-30: 61000000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BARR PHARMACEUTICALS INC · 2006-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Capital Expenditure: 61000000 USD Concept: fundies:CapitalExpenditure Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ACapitalExpenditure&period=2006-06-30&surface=latest&period_type=duration&start=2005-07-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 61000000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-06-011017.txt#16906 The citation records this snapshot. The page link may show a newer release later.	USD 266.34 million Calculation and evidence 327339000 − 61000000 USD Exact free cash flow: 266339000 USD 2005-07-01 – 2006-06-30: 327339000 USD · Inspect Operating Cash Flow · Source 2005-07-01 – 2006-06-30: 61000000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BARR PHARMACEUTICALS INC · 2006-06-30 BARR PHARMACEUTICALS INC (edgar:10081) Free cash flow: 266339000 USD Concept: free-cash-flow Period: 2005-07-01 to 2006-06-30 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 327339000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-06-011017.txt#16861 Input fundies:CapitalExpenditure: 61000000 USD (2005-07-01 to 2006-06-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-06-011017.txt#16906 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 338.16 million Exact value Exact value: -338155000 USD 2006-01-01 – 2006-12-31: -338155000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BARR PHARMACEUTICALS INC · 2006-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Net Income: -338155000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -338155000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#20490 The citation records this snapshot. The page link may show a newer release later.	USD 213.35 million Exact value Exact value: 213346000 USD 2006-01-01 – 2006-12-31: 213346000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BARR PHARMACEUTICALS INC · 2006-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Operating Cash Flow: 213346000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 213346000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21060 The citation records this snapshot. The page link may show a newer release later.	USD 33.67 million Exact value Exact value: 33667000 USD 2006-01-01 – 2006-12-31: 33667000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BARR PHARMACEUTICALS INC · 2006-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Capital Expenditure: 33667000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33667000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21129 The citation records this snapshot. The page link may show a newer release later.	USD 179.68 million Calculation and evidence 213346000 − 33667000 USD Exact free cash flow: 179679000 USD 2006-01-01 – 2006-12-31: 213346000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 33667000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BARR PHARMACEUTICALS INC · 2006-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Free cash flow: 179679000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 213346000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21060 Input fundies:CapitalExpenditure: 33667000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21129 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	USD 128.35 million Exact value Exact value: 128350000 USD 2007-01-01 – 2007-12-31: 128350000 USD Inspect Net Income Open source Share or cite Citation for Net Income · BARR PHARMACEUTICALS INC · 2007-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Net Income: 128350000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: 128350000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#20490 The citation records this snapshot. The page link may show a newer release later.	USD 383.19 million Exact value Exact value: 383187000 USD 2007-01-01 – 2007-12-31: 383187000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BARR PHARMACEUTICALS INC · 2007-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Operating Cash Flow: 383187000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 383187000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21060 The citation records this snapshot. The page link may show a newer release later.	USD 123.36 million Exact value Exact value: 123358000 USD 2007-01-01 – 2007-12-31: 123358000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BARR PHARMACEUTICALS INC · 2007-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Capital Expenditure: 123358000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 123358000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21129 The citation records this snapshot. The page link may show a newer release later.	USD 259.83 million Calculation and evidence 383187000 − 123358000 USD Exact free cash flow: 259829000 USD 2007-01-01 – 2007-12-31: 383187000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 123358000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BARR PHARMACEUTICALS INC · 2007-12-31 BARR PHARMACEUTICALS INC (edgar:10081) Free cash flow: 259829000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:12:25Z Snapshot: 10e6bf23517e5a0c6a9ffeb174ba8203155b2fb5180cd7f52ee174b7beab117b Dimensions: Consolidated View: https://fundies.io/companies/edgar/10081?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 383187000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21060 Input fundies:CapitalExpenditure: 123358000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/10081/0000950123-08-002346.txt#21129 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

76 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000010081, 10081, edgar:10081

Also known as BARR LABORATORIES INC

BARR PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation